コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 of their propensity to spontaneously develop arterial lesions.
2 co-localizes with macrophages within murine arterial lesions.
3 that have localized at sites of experimental arterial lesions.
4 raft dysfunction relies on the assessment of arterial lesions.
5 only after histopathologic evaluation of the arterial lesions.
6 anti-inflammatory M2 phenotype in spleen and arterial lesions.
7 ) for evaluating severely calcified coronary arterial lesions.
8 onal properties of resident B cells in human arterial lesions.
9 of 942 patients underwent PI to treat 2,450 arterial lesions (2,365 stenoses or occlusions, 85 aneur
11 onstrated reduced KIS gene expression within arterial lesions and these lesions were significantly sm
12 intima is a key event in the development of arterial lesions, apoptosis of VSMCs also plays an impor
14 baseline NIHSS score, lesion volume on DWI, arterial lesion by magnetic resonance angiography, and c
15 hat MMP-9 is critical for the development of arterial lesions by regulating both SMC migration and pr
16 this was paralleled by a marked reduction in arterial lesion C3 deposition despite similar levels of
17 fatal arterial event or any new or worsening arterial lesions detected by systematic head-to-pelvis c
18 chromosome 6 gene, which we call Artles (for arterial lesions), did not affect endothelial cell respo
23 xacerbates injury- or hyperlipidemia-induced arterial lesion formation in mice, possibly by excessive
28 iting endothelial regeneration and promoting arterial lesion growth in conditions of endothelial inju
36 percentage of the volume of human restenotic arterial lesions is occupied by extracellular matrix (EC
37 ion into lipid-laden macrophages at sites of arterial lesions, leading to the development of atherosc
38 ix metalloproteinase 9 (MMP-9) is present in arterial lesions of GCA and may be involved in its patho
40 that contrast gradient attenuation along an arterial lesion, or transluminal attenuation gradient (T
44 Chronic rejection in xenografts involves arterial lesions that bear some histological similaritie
45 e characterized by cholesterol-induced focal arterial lesions that impair oxygen delivery to the hear
46 BP allows IFAS to improve early subclinical arterial lesions that tend to progress to plaques and cl
52 ection is characterized by the appearance of arterial lesions with concentric intimal thickening.